NET PROFIT (x1000 DKK)
EMPLOYEES
Neuronano AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
77
|
19
|
45 |
| Earnings before taxes |
-2,019
|
-1,468
|
-1,681 |
| EBITDA |
-1,273
|
-993
|
-1,308 |
| Total assets |
64,405
|
45,878
|
41,749 |
| Current assets |
12,322
|
388
|
6,614 |
| Current liabilities |
2,288
|
3,240
|
873 |
| Equity capital |
62,117
|
42,638
|
40,876 |
| - share capital |
139
|
124
|
120 |
| Employees (average) |
9
|
9
|
6 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
96.4%
|
92.9%
|
97.9% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
-3.0%
|
-3.2%
|
-3.9% |
| Current ratio |
538.5%
|
12.0%
|
757.6% |
| Return on equity (ROE) |
-3.3%
|
-3.4%
|
-4.1% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
3
|
0 |
| Chg. No. of employees % |
0%
|
50%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.